Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0001A
|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine mRNA-LNP spike protein preservative free 30 mcg/0.3mL dosage diluent reconstituted; first dose
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Immunization Administration | Active |
|
|
0001F
|
Heart failure assessed (includes assessment of all the following components) (CAD HF): Blood pressure measured (2000F) Level of activity assessed (1003F) Clinical symptoms of volume overload (excess) assessed (1004F) Weight recorded (2001F) Clinical signs of volume overload (excess) assessed (2002F)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Composite Measures | Active |
|
|
0001M
|
Infectious disease chronic hepatitis C virus (HCV) infection six biochemical assays (ALT A2-macroglobulin apolipoprotein A-1 total bilirubin GGT and haptoglobin) utilizing serum prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
0002A
|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine mRNA-LNP spike protein preservative free 30 mcg/0.3mL dosage diluent reconstituted; second dose
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Immunization Administration | Active |
|
|
0003A
|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine mRNA-LNP spike protein preservative free 30 mcg/0.3 mL dosage diluent reconstituted; third dose
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Immunization Administration | Active |
|
|
0004A
|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine mRNA-LNP spike protein preservative free 30 mcg/0.3 mL dosage diluent reconstituted; booster dose
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Immunization Administration | Active |
|
|
0004U
|
Infectious disease (bacterial) DNA 27 resistance genes PCR amplification and probe hybridization in microarray format (molecular detection and identification of AmpC carbapenemase and ESBL coding genes) bacterial culture colonies report of genes detected or not detected per isolate
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0005F
|
Osteoarthritis assessed (OA) Includes assessment of all the following components: Osteoarthritis symptoms and functional status assessed (1006F) Use of anti-inflammatory or over-the-counter (OTC) analgesic medications assessed (1007F) Initial examination of the involved joint(s) (includes visual inspection palpation range of motion) (2004F)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Composite Measures | Active |
|
|
0005M
|
Fetal aneuploidy (trisomy 21 18 and 13) DNA sequence analysis of selected regions using maternal plasma algorithm reported as a risk score for each trisomy
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
0006U
|
Detection of interacting medications substances supplements and foods 120 or more analytes definitive chromatography with mass spectrometry urine description and severity of each interaction identified per date of service
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0008M
|
Oncology (breast) mRNA analysis of 58 genes using hybrid capture on formalin-fixed paraffin-embedded (FFPE) tissue prognostic algorithm reported as a risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
0009M
|
Fetal aneuploidy (trisomy 21 and 18) DNA sequence analysis of selected regions using maternal plasma algorithm reported as a risk score for each trisomy
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
00100
|
Anesthesia for procedures on salivary glands including biopsy
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Anesthesia for Procedures on the Head | Active |
|
|
00102
|
Anesthesia for procedures involving plastic repair of cleft lip
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Anesthesia for Procedures on the Head | Active |
|
|
00103
|
Anesthesia for reconstructive procedures of eyelid (eg blepharoplasty ptosis surgery)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Anesthesia for Procedures on the Head | Active |
|
|
00104
|
Anesthesia for electroconvulsive therapy
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Anesthesia for Procedures on the Head | Active |
|
|
0010M
|
Oncology (high-grade prostate cancer) biochemical assay of four proteins (Total PSA Free PSA Intact PSA and human kallikrein-2 [hK2]) utilizing plasma or serum prognostic algorithm reported as a probability score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
0011A
|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine mRNA-LNP spike protein preservative free 100 mcg/0.5mL dosage; first dose
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Immunization Administration | Active |
|
|
0011M
|
Onc prst8 ca mrna 12 gen alg
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Multianalyte Assay | Active |
|
|
00120
|
Anesthesia for procedures on external middle and inner ear including biopsy; not otherwise specified
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Anesthesia for Procedures on the Head | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.